Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Avantor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 04, 2025 (GLOBE NE ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against KBR, Inc. due to allegations of false and misleading statements related to the Global Household Goods Contract with the U.S. Department of Defense, which led to significant investor losses [1][2]. Group 1: Allegations and Legal Actions - The complaint alleges that KBR and its executives violated federal securities laws by failing to disclose material concerns regarding HomeSafe's ability to fulfill the Global Household Goods Contract, despite being aware of these issues [2]. - The lawsuit claims that KBR's statements about its business operations and prospects were materially false and misleading, resulting in investor damages when the true details became public [2]. - Following the announcement of the termination of the Global Household Goods Contract, KBR's stock price fell by $3.85 (7.29%) to close at $48.93 on June 20, 2025, and further dropped by $1.30 (2.65%) to close at $47.63 on June 23, 2025 [3]. Group 2: Investor Information - Investors who suffered losses exceeding $50,000 in KBR between May 6, 2025, and June 19, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1]. - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against KBR is November 18, 2025 [1][4]. - Faruqi & Faruqi invites anyone with information regarding KBR's conduct, including whistleblowers and former employees, to reach out to the firm [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, encouraging affected investors to contact them directly [1][3][4]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false or misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [3]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits, citing a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [4]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [5]. Group 2: Legal Proceedings and Investor Actions - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against Marex is December 8, 2025, with the lead plaintiff being the investor with the largest financial interest [1][6]. - Faruqi & Faruqi encourages anyone with information regarding Marex's conduct, including whistleblowers and former employees, to come forward [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against WPP plc due to allegations of false and misleading statements regarding the company's expected revenue for fiscal year 2025, which may have led to artificially inflated stock prices [2][3]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in WPP between February 27, 2025, and July 8, 2025, to discuss their legal options, with a deadline of December 8, 2025, to seek the role of lead plaintiff in a federal securities class action [1][2]. Allegations Against WPP - The complaint alleges that WPP and its executives violated federal securities laws by making false statements and failing to disclose material information about the company's media division, which was not equipped to handle macroeconomic challenges and was losing market share [2][3]. Stock Price Reaction - Following WPP's trading update on July 9, 2025, which indicated a deterioration in performance, the company's stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking an approximate decline of 18.1% in one day [4].

Core Points - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act [3][7] - The lawsuit claims that investors who purchased Semler securities between March 10, 2021, and April 15, 2025, suffered damages when the true details of the investigation were revealed [3][7] Allegation Details - The complaint alleges that Semler Scientific failed to disclose a material investigation by the DOJ while discussing potential violations of the False Claims Act in hypothetical terms [3] - Defendants' public statements were claimed to be materially false and misleading throughout the class period [3] Next Steps - Investors who acquired Semler shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information regarding their rights and potential claims [4][7] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. due to alleged violations of federal securities laws, particularly concerning undisclosed investigations by the DOJ and misleading public statements [1][2]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Semler Scientific between March 10, 2021, and April 15, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Semler Scientific, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [1][4]. - The complaint alleges that Semler Scientific and its executives failed to disclose a material investigation by the DOJ regarding violations of the False Claims Act [2]. Group 2: Financial Impact and Stock Performance - Semler Scientific's 2024 annual report revealed that initial settlement discussions with the DOJ began on February 11, 2025, but were ceased on the same day, indicating potential risks of a civil lawsuit [3]. - Following the disclosure of the DOJ investigation, Semler Scientific's stock fell over 9% on the next trading day [3]. Group 3: Participation and Whistleblower Information - Any member of the putative class can move the court to serve as lead plaintiff or remain an absent class member, with no impact on their ability to share in any recovery [4]. - The firm encourages whistleblowers, former employees, and shareholders with information regarding Semler Scientific's conduct to come forward [4].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Unicycive Therapeutics, Inc. due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by October 14, 2025 [2][4]. Group 1: Company Overview - Unicycive Therapeutics, Inc. is a company listed on NASDAQ under the ticker UNCY [2]. - The firm Faruqi & Faruqi has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 2: Allegations and Stock Performance - The complaint against Unicycive alleges that the company and its executives made false or misleading statements regarding their readiness to meet FDA manufacturing compliance requirements and the regulatory prospects of their OLC NDA [4]. - Following a press release on June 10, 2025, regarding FDA deficiencies, Unicycive's stock price dropped by $3.68 per share, a decline of 40.89%, closing at $5.32 per share [5]. - On June 30, 2025, after the FDA issued a Complete Response Letter citing the same deficiencies, the stock fell by $2.03 per share, or 29.85%, closing at $4.77 per share [6]. Group 3: Legal Proceedings - Investors who suffered losses exceeding $50,000 between March 29, 2024, and June 27, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the ability to direct and oversee the litigation [7].

Group 1 - The article discusses the encouragement from Faruq & Faruq, LLP for investors who suffered losses exceeding $75,000 in LifeMD to reach out for legal options [1] - The specified time frame for the losses is between May 7, 2025, and August 5, 2025 [1] - Contact information for legal inquiries is provided, including phone numbers for direct communication with partner Josh Wilson [1]